The Surterra Wellness Dream +CBN tincture marks the fifth first-to-market product innovation the company has launched in the Lone Star State in the last nine months, following the launch of Texas' first medical cannabis capsule format for qualifying patients. Earlier this week, Parallel's Massachusetts retail brand, New England Treatment Access (NETA), launched a Surterra Wellness Dream +CBN product, making it the first CBN product offered to its customers.
"We are excited to debut yet another first-to-market cannabis product in Texas and to extend our Surterra Wellness line into the Massachusetts market with the launch of Dream +CBN. Our proprietary formulas are crafted to help qualifying patients improve their quality of sleep, which is a big contributor to overall health and well-being," said William "Beau" Wrigley, Jr., Chief Executive Officer and Chairman of Parallel. "Dream +CBN exemplifies Parallel's emphasis on bringing patients a wide variety of innovative product formats and proprietary cannabinoid blends through our dedicated R&D team."
In Texas, the Dream +CBN product line comes in a 15 mg dose of CBN and THC per milliliter (ml), contains a proprietary Dream terpene profile, and is infused with the cannabinoid ratio of 2 CBN:1 THC.
"goodblend Texas is proud to be the first medical cannabis dispensary in Texas to offer a product with the rare cannabinoid CBN to qualifying patients across the Lone Star State through the Compassionate Use Program,” said Marcus Ruark, president of goodblend Texas. “Good quality sleep is essential to overall health and well-being, and we are excited to provide qualifying patients a high-quality alternative to sleep aids to help them feel rested and restored.”
The CBN product’s launch follows the recent news that Parallel has invested $25 million in a new cannabis cultivation, production, and retail facility in San Marcos, Texas. The 63,000-sq.-ft. facility is expected to create hundreds of new jobs in the San Marcos region over the coming years.
The company also recently introduced its goodblend retail brand, which reflects Parallel's intent to provide patients a trusted, consistent and seamless way to connect and learn, and to access cannabis products in a variety of formulations.